FDA backs YouthBio’s alzheimer’s gene therapy
CISION PR Newswire - 25-Sep-2025YB002 showed memory rescue in mice; FDA feedback clears path for first human trial
CISION PR Newswire
Premier global provider of multimedia platforms and distribution
PR Newswire was a distributor of press releases headquartered in New York City. The service was created in 1954 to allow companies to electronically send press releases to news organizations, at first using teleprinters. The founder, Herbert Muschel, operated the service from his house in Manhattan for approximately 15 years. The business was eventually sold to Western Union and then United Newspapers of London. In December 2015, Cision Inc. announced it would acquire the company. On January 1, 2021, Cision formally merged PR Newswire into the company, ending its status as a legal entity after 66 years. Cision plans to continue utilizing the brand name for the foreseeable future in the United States, as well as in Europe and the Asia-Pacific regions.
Visit website: https://www.prnewswire.com/
Details last updated 04-Feb-2019
Articles sourced from CISION PR Newswire
Breakthrough drug LM11A-31 shows promise in Alzheimer's treatment
CISION PR Newswire - 17-May-2024A new drug targets key Alzheimer’s mechanisms, offering hope for combination treatments
Seragon's anti-aging drug candidate extends healthspan and lifespan in mice
CISION PR Newswire - 07-May-2024SRN-901 increases longevity gene expression and reduces aging activity
Turn Biotechnologies delivers mRNA to skin layers without affecting other organs
CISION PR Newswire - 07-Nov-2023Opens avenues for novel drug therapies previously deemed impossible
Gate Bioscience, backed by a $60M funding, introduces new class of small molecule drugs
CISION PR Newswire - 01-Nov-2023The novel drugs called molecular gates eliminate disease-causing proteins
Turn Bio reverses multiple hallmarks of aging in human skin
CISION PR Newswire - 06-Dec-2022Epigenetic reprogramming restores the production of collagen and elastin
Vitalunga creates oral drug to prevent diseases in aging adults
CISION PR Newswire - 13-Jul-2022Positive results in lab tests suggest the drug may improve lifespan and life quality
Lifespan of middle-aged mice increased by a third with telomerase gene therapy
CISION PR Newswire - 19-May-2022Treatment used proprietary CMV vector which is able to deliver multiple genes into the nucleus
YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO
CISION PR Newswire - 14-Apr-2022Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line
Rejuveron raises $20 million for Endogena to advance treatment for eye diseases
CISION PR Newswire - 31-Dec-2021Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration
Small mobile stem cells finds use in cell therapy for lung conditions
CISION PR Newswire - 02-Mar-2021SMS cells play a significant role in lung repair and regeneration, and other inflammatory diseases
Bionic eye implant will restore vision to the blind
CISION PR Newswire - 16-Feb-2021Medical Research Future Fund Grants AU $1M to progress vision processing software
Are Longeveron's Mesenchymal Stem Cells effective against frailty in ageing?
CISION PR Newswire - 01-Jun-2020Japan's Pharmaceutical and Medical Devices Agency gives the green light for human trials
GlycanAge offers free biological age blood tests in the UK
CISION PR Newswire - 29-Apr-20201,000 free tests available in May - but be quick, my names already on the list!
Oral treatment for wet age-related macular degeneration passes Phase 2a trials
CISION PR Newswire - 17-Dec-2018Intriguing hint that this treatment may have potential for other age-related diseases
Cibinetide Shows Promising Signs in Anti-Aging
CISION PR Newswire - 02-May-2018Cibinetide works via activating the body's innate repair receptor (IRR) Capable of decreasing ag...
DanBrit acquires Enochian Biopharm to expand its immunotherapy pipeline
CISION PR Newswire - 23-Jan-2018Will rebrand as Enochian and also move to Los Angeles
Global Foundation for Human Aging Research Donates $50K Harvard Medical School
CISION PR Newswire - 21-Jun-2017Sinclair Lab studies the processes that drive aging and age-related diseases. Doing impressive w...
